Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Events Partner Content SMi's 9th annual Biosimilars & Biobetters Biosimilars & Biobetters conference information
Partner Content Partner Content Agenda Released for USA Biosimilars Conference this November Agenda Released for USA Biosimilars Conference this Nov
Partner Content Partner Content Industry experts set to transform evolving pre-approval & un... Created in response to unprecedented global demand from patients and physicians and to provide a long-sought after alternative for the biopharma
News GSK says Nucala hits the target in new COPD trial GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.